Calidi Biotherapeutics, Inc. · AMEX:CLDI
Calidi Biotherapeutics, Inc. shareholders
As of Jun 30, 2026, 23 institutions reported holding Calidi Biotherapeutics, Inc., 20.3% of its shares. Largest: Geode Capital, HighTower Advisors, LLC and Jane Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Calidi Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Geode Capital | 115K | 4.4% | +51,531 | Aug 12, 2026 |
| HighTower Advisors, LLC | 83,523 | 3.2% | no change | Aug 26, 2026 |
| Jane Street | 54,274 | 2.1% | +19,472 | Aug 14, 2026 |
| Independent Advisor Alliance | 45,000 | 1.7% | held for review | Aug 12, 2026 |
| Rs Crum Inc. | 43,239 | 1.7% | +2,983 | Aug 10, 2026 |
| Arax Advisory Partners | 37,345 | 1.4% | no change | Aug 10, 2026 |
| Private Advisor Group, LLC | 30,000 | 1.2% | new | Jul 27, 2026 |
| Vanguard | 25,509 | 0.99% | no change | Aug 13, 2026 |
| Belpointe Asset Management LLC | 19,921 | 0.77% | no change | Jul 31, 2026 |
| Northern Trust | 17,758 | 0.69% | no change | Aug 13, 2026 |